Alliance IB Research upgrades BAT to Neutral, raises target price
Page 1 of 1
Alliance IB Research upgrades BAT to Neutral, raises target price
Alliance IB Research upgrades BAT to Neutral, raises target price |
Business & Markets 2013 |
Written by theedgemalaysia.com |
Friday, 11 October 2013 08:03 |
In a note Oct 10, the research house concluded that as such, the cigarette price hike would have a mildly positive impact on BAT’s bottomline.
“Thus, we raise our earnings forecast by 3.1%-8.3% for FY13-FY15, respectively, which prompted us to upgrade our recommendation on BAT from sell to Neutral.
“Correspondingly, we also raise our target price from RM54.72 to RM60.66, based on FCFF valuation method,” it said.
Cals- Administrator
- Posts : 25277 Credits : 57721 Reputation : 1766
Join date : 2011-09-08
Location : global
Comments : “My plan of trading was sound enough and won oftener that it lost. If I had stuck to it Iâ€d have been right perhaps as often as seven out of ten times.â€
Stock Exposure : Technical Analysis / Fundamental Analysis / Mental Analysis
Similar topics
» Affin IB Research upgrades AFG to Buy, raises target price
» CIMB Research upgrades F&N to Add, raises target price
» MIDF Research upgrades MSM to Trading Buy, raises target price
» Affin IB Research upgrades Supermax to Buy, raises target price
» HLIB Research upgrades ViTrox to Buy, raises target price to RM3.17
» CIMB Research upgrades F&N to Add, raises target price
» MIDF Research upgrades MSM to Trading Buy, raises target price
» Affin IB Research upgrades Supermax to Buy, raises target price
» HLIB Research upgrades ViTrox to Buy, raises target price to RM3.17
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
|
|